147 related articles for article (PubMed ID: 27016671)
21. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.
Sekine R; Kitamura T; Tsuji T; Tojo A
Int J Hematol; 2008 May; 87(4):351-362. PubMed ID: 18415655
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
23. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
[TBL] [Abstract][Full Text] [Related]
24. All oligosaccharide moieties of the μ chains in the pre-BCR are of the high-mannose type.
Haimovich J; Ben Moshe N; Raviv Y; Hollander N
Mol Immunol; 2010; 48(1-3):351-5. PubMed ID: 20801511
[TBL] [Abstract][Full Text] [Related]
25. Tungsten Blocks Murine B Lymphocyte Differentiation and Proliferation Through Downregulation of IL-7 Receptor/Pax5 Signaling.
Wu TH; Bolt AM; Chou H; Plourde D; De Jay N; Guilbert C; Young YK; Kleinman CL; Mann KK
Toxicol Sci; 2019 Jul; 170(1):45-56. PubMed ID: 30912803
[TBL] [Abstract][Full Text] [Related]
26. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
27. Distorted antibody repertoire developed in the absence of pre-B cell receptor formation.
Sun L; Kono N; Shimizu T; Toh H; Xue H; Numata O; Ato M; Itamura S; Ohnishi K
Biochem Biophys Res Commun; 2018 Jan; 495(1):1411-1417. PubMed ID: 29191653
[TBL] [Abstract][Full Text] [Related]
28. Science Signaling Podcast for 29 November 2016: Pre-B cell receptor signaling in leukemia.
Wilson BS; VanHook AM
Sci Signal; 2016 Nov; 9(456):c23. PubMed ID: 27899524
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.
Fidanza M; Seif AE; DeMicco A; Rolf N; Jo S; Yin B; Li Y; Barrett DM; Duque-Afonso J; Cleary ML; Bassing CH; Grupp SA; Reid GS
Leukemia; 2016 Oct; 30(10):2116-2119. PubMed ID: 27220664
[No Abstract] [Full Text] [Related]
30. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
31. Losing B cell identity.
Carotta S; Nutt SL
Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
[TBL] [Abstract][Full Text] [Related]
32. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
[TBL] [Abstract][Full Text] [Related]
33. The selection of mature B cells is critically dependent on the expression level of the co-receptor CD19.
von Muenchow L; Engdahl C; Karjalainen K; Rolink AG
Immunol Lett; 2014 Aug; 160(2):113-9. PubMed ID: 24472602
[TBL] [Abstract][Full Text] [Related]
34. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.
Revilla-I-Domingo R; Bilic I; Vilagos B; Tagoh H; Ebert A; Tamir IM; Smeenk L; Trupke J; Sommer A; Jaritz M; Busslinger M
EMBO J; 2012 Jun; 31(14):3130-46. PubMed ID: 22669466
[TBL] [Abstract][Full Text] [Related]
35. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
[TBL] [Abstract][Full Text] [Related]
36. Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways.
Sanz E; Muñoz-A N; Monserrat J; Van-Den-Rym A; Escoll P; Ranz I; Alvarez-Mon M; de-la-Hera A
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5925-30. PubMed ID: 20231472
[TBL] [Abstract][Full Text] [Related]
37. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
38. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
39. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
[TBL] [Abstract][Full Text] [Related]
40. [Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma].
Yuan XL; Zhang B; Jiang LM; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):799-803. PubMed ID: 18718064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
